We are live on !
Find out more
UBS Portfolio holdings
AUM
$136B
Turnover
18.95%
1-Year Est. Return
16.36%
This Fund
S&P 500
This Quarter Est. Return
-0.23%
1 Year Est. Return
+16.36%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$136B
AUM Growth
+$7.83B
(+6.1%)
Cap. Flow
+$3.56B
Cap. Flow % of AUM
Cap. Flow %
2.62%
Top 10 Holdings %
Top 10 Hldgs %
13.26%
Holding
11,505
New
1,064
Increased
4,754
Reduced
3,910
Closed
1,116
Avg Time Held
Equity + Options
1
year
Top 10 Avg Time Held
Equity + Options
0.8
years
Top 20 Avg Time Held
Equity + Options
0.8
years
Avg Time Held Equity only
1
year
Top 10 Avg Time Held Equity only
0.9
years
Top 20 Avg Time Held Equity only
1
year
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$387M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$346M |
| 3 |
Crown Castle
CCI
|
+$229M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$218M |
| 5 |
Toronto Dominion Bank
TD
|
+$195M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.62B |
| 2 |
APA Corp
APA
|
+$473M |
| 3 |
FDO
FAMILY DOLLAR STORES
FDO
|
+$453M |
| 4 |
Herc Holdings
HRI
|
+$322M |
| 5 |
PETM
PETSMART INC
PETM
|
+$311M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 47.72% |
| 2 | Energy | 9.22% |
| 3 | Financials | 6.8% |
| 4 | Healthcare | 6.74% |
| 5 | Technology | 6.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2776
CALL
Himax Technologies
HIMX
$1.97B
| $2.27M | ﹤0.01% |
223,500
+55,300
| +33% | +$418K |
2013 Q2
5 quarters
|
|
2777
DELISTED
CLECO CRP (HOLDING CO)
CNL
| $2.26M | ﹤0.01% |
47,013
-2,219
| -5% | -$123K |
2013 Q2
5 quarters
|
|
|
GNC
2778
DELISTED
GNC Holdings, Inc.
GNC
| $2.26M | ﹤0.01% |
58,391
-25,918
| -31% | -$941K |
2013 Q2
5 quarters
|
|
2779
Gildan
GIL
$7.5B
| $2.26M | ﹤0.01% |
82,622
-8,640
| -9% | -$250K |
2013 Q2
5 quarters
|
|
|
GFA
2780
DELISTED
Gafisa S.A.
GFA
| $2.26M | ﹤0.01% |
70,063
-940
| -1% | -$36.5K |
2013 Q2
5 quarters
|
|
|
LFC
2781
DELISTED
China Life Insurance Company Ltd.
LFC
| $2.26M | ﹤0.01% |
162,303
+30,219
| +23% | +$435K |
2013 Q2
5 quarters
|
|
|
MEMP
2782
PUT
DELISTED
Memorial Production Partners LP Common Units
MEMP
| $2.25M | ﹤0.01% |
102,400
+100,800
| +6,300% | +$2.33M |
2013 Q4
3 quarters
|
|
2783
CALL
Brightstar Lottery PLC
BRSL
$1.73B
| $2.25M | ﹤0.01% |
133,500
+115,500
| +642% | +$1.92M |
2013 Q2
5 quarters
|
|
2784
NewMarket
NEU
$8.01B
| $2.25M | ﹤0.01% |
5,897
+1,226
| +26% | +$486K |
2013 Q2
5 quarters
|
|
2785
PUT
AbbVie
ABBV
$505B
| $2.25M | ﹤0.01% |
38,900
+29,400
| +309% | +$1.63M |
2013 Q2
5 quarters
|
|
2786
National Health Investors
NHI
$3.29B
| $2.24M | ﹤0.01% |
39,295
-3,675
| -9% | -$228K |
2013 Q2
5 quarters
|
|
2787
CALL
Matador Resources
MTDR
$7.42B
| $2.24M | ﹤0.01% |
86,800
-1,700
| -2% | -$44.8K |
2013 Q2
5 quarters
|
|
|
HZNP
2788
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $2.24M | ﹤0.01% |
182,733
-11,336
| -6% | -$132K |
2013 Q2
5 quarters
|
|
2789
CALL
Medtronic
MDT
$122B
| $2.24M | ﹤0.01% |
36,200
+12,100
| +50% | +$769K |
2013 Q2
5 quarters
|
|
2790
Mizuho Financial
MFG
$116B
| $2.24M | ﹤0.01% |
627,873
+61,568
| +11% | +$237K |
2013 Q2
5 quarters
|
|
|
LDR
2791
DELISTED
Landauer Inc
LDR
| $2.24M | ﹤0.01% |
67,930
+28,947
| +74% | +$1.11M |
2013 Q2
5 quarters
|
|
2792
Green Dot
GDOT
$704M
| $2.23M | ﹤0.01% |
105,506
+43,849
| +71% | +$823K |
2013 Q2
5 quarters
|
|
2793
DELISTED
SANDRIDGE ENERGY, INC.
SD
| $2.23M | ﹤0.01% |
519,202
-100,782
| -16% | -$563K |
2013 Q2
5 quarters
|
|
2794
DELISTED
CSG Systems International
CSGS
| $2.22M | ﹤0.01% |
84,684
+12,986
| +18% | +$351K |
2013 Q2
5 quarters
|
|
|
BSCM
2795
DELISTED
Invesco BulletShares 2022 Corporate Bond ETF
BSCM
| $2.22M | ﹤0.01% |
107,660
+11,340
| +12% | +$236K |
2013 Q3
4 quarters
|
|
2796
Chemed
CHE
$6.7B
| $2.22M | ﹤0.01% |
21,615
+19,945
| +1,194% | +$2.02M |
2013 Q2
5 quarters
|
|
2797
Ellington Financial
EFC
$1.51B
| $2.22M | ﹤0.01% |
100,099
+43,578
| +77% | +$1.04M |
2013 Q2
5 quarters
|
|
2798
Nuveen Core Equity Alpha Fund
JCE
$287M
| $2.22M | ﹤0.01% |
129,336
+11,639
| +10% | +$209K |
2013 Q2
5 quarters
|
|
2799
CALL
Myriad Genetics
MYGN
$557M
| $2.21M | ﹤0.01% |
57,400
-6,400
| -10% | -$239K |
2013 Q2
5 quarters
|
|
2800
DELISTED
Monroe Capital Corp
MRCC
| $2.21M | ﹤0.01% |
163,937
-38,365
| -19% | -$522K |
2013 Q3
4 quarters
|
|
Similar funds
MGC
UBS's Q3 2014 Portfolio in Review
As of Q3 2014, UBS held 11,505 positions worth $136B, up 6.1% from $128B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS's Q3 2014 filing shows 1,064 new, 4,754 increased, 3,910 reduced and 1,116 closed positions. Its largest new stake was Alibaba: 1,105,926 shares worth $98.3M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.62B.
By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, up from 47% a quarter earlier, followed by Energy and Financials.
- UBS's largest Q3 2014 buy was Alibaba: 1,105,926 shares worth $98.3M.
- UBS added most to Amgen in Q3 2014, an estimated $387M increase.
- UBS's biggest Q3 2014 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.62B.
- UBS fully exited SUSSER HOLDINGS CORPORATION COMMON STOCK in Q3 2014, selling an estimated $81.1M.
- UBS's ten largest holdings make up 13% of its $136B portfolio in Q3 2014.
- UBS opened 1,064 new positions and closed 1,116 in Q3 2014.
- UBS's portfolio value rose 6.1% quarter-over-quarter to $136B.
Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.